<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Authors on ENDOMIC Team</title>
    <link>/authors/</link>
    <description>Recent content in Authors on ENDOMIC Team</description>
    <generator>Source Themes academia (https://sourcethemes.com/academic/)</generator>
    <language>en-us</language>
    <copyright>Copyright &amp;copy; {year}</copyright>
    <lastBuildDate>Tue, 27 Sep 2022 00:00:00 +0000</lastBuildDate>
    
	    <atom:link href="/authors/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title></title>
      <link>/authors/admin/</link>
      <pubDate>Tue, 27 Sep 2022 00:00:00 +0000</pubDate>
      
      <guid>/authors/admin/</guid>
      <description>&lt;p&gt;&lt;strong&gt;Chronic inflammatory diseases&lt;/strong&gt; (CID) mainly affect young people with a significant impact on quality of life, family and socio-professional life. They also have a significant impact on healthcare budgets due to the increasing costs of their care.  CID is characterized by a significant variability in clinical presentation, biological profiles and evolution; this clinical heterogeneity complicates the management of patients and could explain the failure of therapeutic trials. It appears necessary to better define the clinical phenotypes in order to better understand the physiopathological mechanisms and to better target the evaluation of new therapies. This is in line with the concept of &amp;ldquo;&lt;strong&gt;endotype&lt;/strong&gt;&amp;rdquo; which can be considered as a subtype of disease defined functionally and pathologically by a molecular mechanism or a particular response to a treatment.&lt;/p&gt;
&lt;p&gt;&lt;a href=&#34;https://endomic.github.io/&#34;&gt;&lt;strong&gt;ENDOMIC&lt;/strong&gt;&lt;/a&gt; (ENDOtyper les Maladies Inflammatoires Chroniques) specializes in precision medicine approaches using health data and artificial intelligence, which is part of the dynamics of our academic site (France 2030 Excellence Initiative including the University of Lille, the &lt;a href=&#34;https://www.chu-lille.fr/&#34;&gt;Lille University Hospital&lt;/a&gt;, &lt;a href=&#34;https://www.inserm.fr/&#34;&gt;INSERM&lt;/a&gt; and &lt;a href=&#34;https://www.inria.fr/en&#34;&gt;INRIA&lt;/a&gt;).&lt;/p&gt;
&lt;img src=&#34;logos_all.jpg&#34; width=&#34;700&#34;&gt;
&lt;!-- ![reviews](../../img/certifacates.jpg) 

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum. The point of using Lorem Ipsum. distracted by the readable content of a page.

--&gt;
</description>
    </item>
    
    <item>
      <title></title>
      <link>/authors/adan/</link>
      <pubDate>Thu, 01 Sep 2022 00:00:00 +0000</pubDate>
      
      <guid>/authors/adan/</guid>
      <description>&lt;p&gt;I am a &lt;a href=&#34;https://pro.univ-lille.fr/adan-jose-garcia/&#34;&gt;Research Fellow in Digital Health&lt;/a&gt; at the Department of Computer Science, &lt;a href=&#34;https://www.cristal.univ-lille.fr/&#34;&gt;CRIStAL Lab&lt;/a&gt;, University of Lille, France. This is a collaborative project with the &lt;a href=&#34;https://www.chu-lille.fr/&#34;&gt;Lille University Hospital&lt;/a&gt; and &lt;a href=&#34;https://include-project.chru-lille.fr/home-project/&#34;&gt;INCLUDE&lt;/a&gt;. My current project involves developing and applying unsupervised machine learning techniques to classify patients with systemic autoimmune diseases.&lt;/p&gt;
&lt;p&gt;Before joining the University of Lille, I was a &lt;a href=&#34;http://emps.exeter.ac.uk/computer-science/staff/aj504&#34;&gt;Research Fellow in Machine Learning&lt;/a&gt; at the Department of Computer Science, Institute of Data Science and Artificial Intelligence, University of Exeter, United Kingdom (UK). Before this, I was a Postdoctoral Researcher with the &lt;a href=&#34;https://www.alliancembs.manchester.ac.uk/research/decision-science/&#34;&gt;Decision and Cognitive Sciences Research Centre&lt;/a&gt;, University of Manchester, UK. I hold M.Sc. and Ph.D. degrees in Computer Science from the Center for Research and Advanced Studies of the National Polytechnic Institute, &lt;a href=&#34;https://www.cinvestav.mx/&#34;&gt;Cinvestav-IPN&lt;/a&gt;, Mexico.&lt;/p&gt;
&lt;p&gt;My research consists in creating clustering approaches (e.g., multi-view clustering, biclustering) and their applications to different research fields such as digital healthcare, labour market and network analysis. My research currently focuses on developing integrative cluster analysis approaches to address healthcare-related data problems and help to understand better disease complications and treatment goals.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title></title>
      <link>/authors/vincent/</link>
      <pubDate>Thu, 01 Sep 2022 00:00:00 +0000</pubDate>
      
      <guid>/authors/vincent/</guid>
      <description>&lt;h1 id=&#34;heading&#34;&gt;&amp;hellip;&lt;/h1&gt;
&lt;p&gt;I am a &lt;a href=&#34;https://pro.univ-lille.fr/vincent-sobanski/&#34;&gt;Professor in Internal Medicine&lt;/a&gt; at the University of Lille and CHU Lille; my research work aims to better characterize the clinical heterogeneity of systemic autoimmune diseases and to understand the role of autoantibodies. As clinical physicians, we are constantly looking for the best tools to diagnose, search for complications or predict prognosis in order to decide on therapeutic management. We already use patient stratification methods for the diseases we are in charge of; new technological tools provide new avenues for research. I have been strongly involved in this theme in the hospital and university community. My academic work is focused on helping to diagnose and stratify patients through new technologies and an integrated approach, building on and developing my own research on rare diseases (autoimmune and fibrotic pathologies), but with a strong commitment to disseminate and use these skills for the entire community.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>David LAUNAY</title>
      <link>/authors/david-launay/</link>
      <pubDate>Thu, 01 Sep 2022 00:00:00 +0000</pubDate>
      
      <guid>/authors/david-launay/</guid>
      <description></description>
    </item>
    
    <item>
      <title></title>
      <link>/authors/solange/</link>
      <pubDate>Fri, 01 Jul 2022 00:00:00 +0000</pubDate>
      
      <guid>/authors/solange/</guid>
      <description>&lt;h1 id=&#34;heading&#34;&gt;&amp;hellip;&lt;/h1&gt;
&lt;p&gt;I joined the ENDOMIC team in 2016 as a study engineer to work on the functional role of autoantibodies in fibrotic diseases, more especially in systemic sclerosis, to define new endotypes linked to the anti-nuclear autoantibodies identified in patients. In 2018, I started a PhD still in the same field of research but focusing on autoimmune paraneoplastic syndromes to understand how cancer and autoimmunity can be linked from a molecular point of view.&lt;/p&gt;
&lt;p&gt;In these two large projects, I bring my expertise in cell biology, biochemistry of proteins, and their analysis by conventional and omics methods. Since my defense in March 2022, I obtained a post-doc position to complete and deepen the works initiated by the implementation of multi-omics data integration methods and more mechanistic experimentations on the effect of autoantibodies in vitro and in vivo.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title></title>
      <link>/authors/aurelien/</link>
      <pubDate>Wed, 01 Jun 2022 00:00:00 +0000</pubDate>
      
      <guid>/authors/aurelien/</guid>
      <description>&lt;h1 id=&#34;heading&#34;&gt;&amp;hellip;&lt;/h1&gt;
&lt;p&gt;Description goes here&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title></title>
      <link>/authors/louisa/</link>
      <pubDate>Wed, 01 Jun 2022 00:00:00 +0000</pubDate>
      
      <guid>/authors/louisa/</guid>
      <description>&lt;h1 id=&#34;heading&#34;&gt;&amp;hellip;&lt;/h1&gt;
&lt;p&gt;Description goes here&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Sylvain DUBUCQUOI</title>
      <link>/authors/sylvain-dubucquoi/</link>
      <pubDate>Wed, 01 Jun 2022 00:00:00 +0000</pubDate>
      
      <guid>/authors/sylvain-dubucquoi/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Vincent KOETHER</title>
      <link>/authors/vincent-koether/</link>
      <pubDate>Wed, 01 Jun 2022 00:00:00 +0000</pubDate>
      
      <guid>/authors/vincent-koether/</guid>
      <description></description>
    </item>
    
    <item>
      <title></title>
      <link>/authors/clement/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      
      <guid>/authors/clement/</guid>
      <description>&lt;h1 id=&#34;heading&#34;&gt;&amp;hellip;&lt;/h1&gt;
&lt;p&gt;Info goes here &amp;hellip;&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
